CHAPTER 1 - MARKET SUMMARY
Market Overview
The Vietnam Ophthalmology Market operates through specialty hospitals, ophthalmology departments, clinics, optical-refraction channels and distributors supplying procedure-linked products. Patient and consumer touchpoints are estimated at 55.6 million in 2025, creating recurring monetization across examinations, prescription correction, surgery, imaging and chronic treatment. The commercial model therefore combines high-frequency routine care with higher-value cataract, refractive and retinal interventions.
Ho Chi Minh City and Hanoi form the principal organized ophthalmology hubs, combining referral hospitals, specialist surgeons and private eye-care networks. Saigon Eye Hospital's network alone includes 28 hospitals and clinics nationwide, while several major providers maintain their highest-value surgical and diagnostic capacity in Vietnam's two largest metropolitan markets. Concentration improves equipment utilization and premium-procedure economics but leaves provincial access comparatively fragmented.
Market Value
USD 791 million
2025
Dominant Region
Ho Chi Minh City
2025
Dominant Segment
Prescription Eyewear
2025
Total Number of Players
120
Future Outlook
The Vietnam Ophthalmology Market is expected to progress from USD 791 million in 2025 toward USD 1,205 million by 2032, representing a 6.20% forecast CAGR. Historical market expansion was stronger at approximately 7.04% during 2020-2025, reflecting the post-pandemic normalization of examinations and elective surgery. Market value is projected to reach approximately USD 1,135 million in 2031 before crossing USD 1.2 billion in 2032. Future expansion is expected to be driven increasingly by premium cataract implants, refractive surgery, retina therapies, imaging platforms and recurring disease-management pathways rather than consultation volume alone.
Patient and consumer touchpoints are projected to approach 79.9 million by 2032 from 55.6 million in 2025, implying slower volume growth than market value and therefore gradual improvement in revenue per treatment interaction. The higher-value mix is reinforced by an ageing population expected to approach 18 million people aged 60 and above by 2030, persistent refractive-error prevalence and wider insured access. Teleophthalmology and digitally assisted screening will remain comparatively small but should expand rapidly, improving provincial case identification and directing complex cases toward metro-based surgical hubs.
6.20%
Forecast CAGR
$1,205 Mn
2030 Projection
Base Year
2025
Historical Period
2020-2025
Forecast Period
2025-2032
Historical CAGR
7.04%
CHAPTER 2 - SCOPE OF REPORT
Scope of the Market
CHAPTER 3 - Key Stakeholders
Key Target Audience
Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning.
Investors
CAGR, procedure mix, ARPU, capex intensity, import risk
Corporates
network expansion, procurement cost, technology depth, pricing power
Government
blindness prevention, insurance access, specialist density, screening coverage
Operators
surgeon productivity, procedure conversion, diagnostics uptime, patient acquisition
Financial institutions
project finance, cash conversion, utilization, repayment durability
CHAPTER 4 - Market Size & Growth
Market Size, Growth Forecast and Trends
This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers.
Historical & Projected Market Size ($ Million)
Year-over-Year Growth Rate (%)
Market Value vs Volume Growth (%)
Historical Market Performance (2020-2025)
The historical cycle began with the 2020 trough at USD 563 million as elective surgery and in-person optical activity were disrupted. Recovery accelerated in 2022, when value increased 10.0%, followed by 8.6% in 2023 and 7.7% in 2024. Patient and consumer touchpoints increased from 39.3 million in 2020 to 55.6 million in 2025. Surgical services expanded from approximately 17.2% to 19.8% of revenue, demonstrating a shift toward higher-value interventions. The 2025 sizing model carries an approximate confidence band of USD 712-870 million, primarily reflecting private-channel revenue disclosure uncertainty.
Forecast Market Outlook (2025-2032)
The base forecast implies 6.20% annual value growth through 2032, taking the market to USD 1,205 million. Patient and consumer touchpoints are expected to approach 79.9 million, implying approximately 5.3% annual volume expansion and a gradual increase in blended revenue per touchpoint from roughly USD 14.2 in 2025 to USD 15.1 in 2032. Growth therefore becomes increasingly mix-led. Premium cataract implants, retinal treatment, refractive procedures, imaging, digital screening and recurring chronic-care pathways should outpace routine consultation revenue, while teleophthalmology's revenue contribution is modeled to rise toward 5.4% by 2032.
CHAPTER 5 - Market Data
Market Breakdown
The Vietnam Ophthalmology Market is moving toward higher-acuity clinical revenue while preserving a broad base of routine examinations and vision correction. For investors and operators, the key issue is whether touchpoint expansion can be converted into premium surgery, diagnostics, disease-management and digital-care revenue.
Year | Market Size (USD Mn) | YoY Growth (%) | Patient/Consumer Touchpoints (Mn) | Ophthalmic Surgical Services Share (%) | Teleophthalmology Revenue Share (%) | Period |
|---|---|---|---|---|---|---|
| 2020 | $563 Mn | +-4.3% | 39.3 | 17.2% | Forecast | |
| 2021 | $579 Mn | +2.8% | 40.6 | 17.5% | Forecast | |
| 2022 | $637 Mn | +10.0% | 45.0 | 18.3% | Forecast | |
| 2023 | $692 Mn | +8.6% | 49.1 | 18.9% | Forecast | |
| 2024 | $745 Mn | +7.7% | 52.8 | 19.5% | Forecast | |
| 2025 | $791 Mn | +6.2% | 55.6 | 19.8% | Forecast | |
| 2026 | $840 Mn | +6.2% | 58.6 | 20.1% | Forecast | |
| 2027 | $892 Mn | +6.2% | 61.7 | 20.4% | Forecast | |
| 2028 | $947 Mn | +6.2% | 65.0 | 20.8% | Forecast | |
| 2029 | $1,006 Mn | +6.2% | 68.5 | 21.2% | Forecast | |
| 2030 | $1,068 Mn | +6.2% | 72.1 | 21.6% | Forecast | |
| 2031 | $1,135 Mn | +6.3% | 75.9 | 22.0% | Forecast | |
| 2032 | $1,205 Mn | +6.2% | 79.9 | 22.4% | Forecast |
Patient/Consumer Touchpoints
55.6 million, 2025, Vietnam. High interaction frequency improves fixed-cost absorption for hospital networks and expands cross-selling into diagnostics and procedures. Vietnam's population reached 102.3 million in 2025.
Ophthalmic Surgical Services Share
19.8%, 2025, Vietnam. Procedure mix is strategically important because cataract and retinal interventions generate higher revenue per patient. Approximately 2 million Vietnamese were blind in 2023, with cataract representing 66.1% of leading causes.
Teleophthalmology Revenue Share
3.0%, 2025, Vietnam. Digital care can reduce specialist bottlenecks and provincial referral leakage. By September 2025, 153 of 164 hospitals in Ho Chi Minh City had implemented electronic medical records, equal to 93% of facilities.
CHAPTER 6 - Segmentation
Market Segmentation Framework
Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns.
No of Segments
7
Dominant Segment
Care Setting
Fastest Growing Segment
Technology
Service Type
Care Setting
End User
Disease Area
Channel
Technology
Geography
Key Segmentation Takeaways
Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns.
Care Setting
Care setting is the dominant strategic segmentation because provider type determines procedure capability, capital intensity, reimbursement exposure and patient acquisition. Single-specialty eye hospitals have the strongest ability to combine diagnostics, surgery and recurring disease management, while multi-specialty hospitals retain referral advantages. Private specialty networks are expanding geographic reach and differentiating through refractive surgery, premium cataract technologies and digital patient engagement.
Technology
Technology is the fastest-growing strategic dimension as operators migrate from conventional refraction and standard surgery toward SMILE-based refractive procedures, premium intraocular lenses, OCT imaging, digital screening and teleophthalmology. AI-assisted screening is particularly attractive because Vietnam's specialist density remains constrained, allowing hospitals to extend diagnostic reach without reproducing tertiary infrastructure in every province.
CHAPTER 7 - Regional Analysis
Regional Analysis
Vietnam ranks third among selected Southeast Asian ophthalmology markets by comparable 2025 market value, behind Indonesia and Thailand but ahead of the Philippines and Malaysia. Its relative advantage is stronger forward growth, expanding insurance access and a large addressable population with rising age-related eye-care requirements.
Focus Country Ranking
3rd
Focus Country Market Size
USD 791 Mn (2025)
Vietnam CAGR (2025-2032)
6.2%
Focus Country Ranking
3rd
Focus Country Market Size
USD 791 Mn (2025)
Vietnam CAGR (2025-2032)
6.2%
Regional Analysis (Current Year)
Market Position
Vietnam ranks 3rd in the selected five-country peer set at approximately USD 791 million in 2025, supported by a large organized provider base and expanding specialist demand.
Growth Advantage
Vietnam's 6.2% CAGR exceeds Thailand's 4.9% and Malaysia's 5.1%, positioning Vietnam as a regional growth challenger with stronger procedure and diagnostic monetization potential.
Competitive Strengths
Vietnam combines 95.2% health-insurance coverage, a population exceeding 102 million and ophthalmology workforce density reported at 16.5 specialists per million in a recent industry workforce assessment.
CHAPTER 8 - INDUSTRY ANALYSIS
Growth Drivers, Challenges & Opportunities
Comprehensive analysis of key factors shaping the Vietnam Ophthalmology Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments.
Growth Drivers
Population Ageing Expands High-Acuity Eye-Care Demand
- The population aged 60 and above is forecast to approach 18 million (2030, Vietnam), increasing recurring need for cataract diagnostics, surgery and age-related retinal monitoring.
- Approximately 2 million people were blind (2023, Vietnam), with cataract accounting for 66.1% (2023, Vietnam) of leading blindness causes, sustaining a substantial surgical need pool.
- Vietnam had approximately 2.5 million adults with diabetes (2024, Vietnam), while 37.8% were undiagnosed, expanding the long-term requirement for diabetic-retinopathy screening and retinal follow-up.
Refractive Error Creates a Large Lifetime Care Funnel
- Pooled refractive-error prevalence among Vietnamese schoolchildren reached 37.60% (studies through 2024, Vietnam), creating a substantial screening, spectacle and myopia-control addressable pool.
- A 2024 Ba Ria-Vung Tau study found refractive error in 32.4% of 432 students (2024, Vietnam), with myopia representing 75% of identified cases.
- A Hue study found myopia in 48.7% of 647 students (2025 publication, Vietnam), while almost two-thirds of myopic students did not wear spectacles, revealing significant unmet correction demand.
Insurance Expansion and Private Capacity Improve Conversion
- Vietnam recorded approximately 195.5 million insured medical visits (2025, Vietnam), demonstrating the scale of reimbursed healthcare utilization available to support ophthalmology referral and treatment volumes.
- Saigon Eye Hospital's specialist network includes 28 hospitals and clinics (2026 network disclosure, Vietnam), demonstrating the scalability of organized private ophthalmology beyond single-city operations.
- Saigon Eye Hospital Vinh reported more than 10,000 Phaco procedures and 1,000 LASIK procedures (2025, Vietnam), illustrating procedure density achievable in a provincial private-eye-hospital model.
Market Challenges
Specialist Capacity Remains Structurally Constrained
- A 2025 clinical publication estimated roughly 1,300 ophthalmologists nationwide (2025 publication, Vietnam), equal to around 1.3 per 100,000 people and insufficient for uniform specialist access.
- Outpatient waiting time at Nghe An Eye Hospital ranged from approximately 20 minutes to 85 minutes (2025, Vietnam) depending on diagnostic complexity, demonstrating capacity pressure inside organized facilities.
- Rural residents represented 61.4% of Vietnam's population (2025, Vietnam), increasing the economic importance of referral networks, remote screening and mobile service delivery outside major specialist hubs.
Imported Technology Raises Procurement and Affordability Risk
- Japan, Switzerland and the United States exported approximately USD 3.64 million, USD 3.45 million and USD 2.64 million (2024, Vietnam destination) respectively under HS 901850, reinforcing multi-country supply exposure.
- Medical-device regulation was amended through Decree 04/2025 with an effective date of 1 January 2025 (2025, Vietnam), requiring distributors and providers to maintain updated compliance processes around device commercialization.
- Approximately one-third of 2 million blind people (2023, Vietnam) were described as poor and unable to afford sight-restoring treatment, demonstrating persistent affordability constraints despite wider insurance participation.
Organized Supply Remains Concentrated in Major Cities
- Ho Chi Minh City's broader healthcare network reached 164 hospitals (2025, Vietnam), including 90 private hospitals, reinforcing the city's advantage in specialist referrals and capital availability.
- Vietnam-Russia International Eye Hospital currently lists 4 major branches (2026, Vietnam), demonstrating national expansion but also the limited physical footprint of premium surgical networks relative to population scale.
- Vietnam National Eye Hospital is listed as a 300-500 bed facility (current registry, Vietnam), underscoring reliance on a relatively small number of large referral institutions for complex ophthalmic care.
Market Opportunities
Teleophthalmology and Digital Screening Can Extend Specialist Reach
- Electronic medical records had been implemented at 153 of 164 Ho Chi Minh City hospitals (September 2025, Vietnam), creating infrastructure for better digital referral and longitudinal ophthalmic records.
- Insured medical utilization reached 143.8 million visits by September 2025 (Vietnam), giving digital triage and referral tools a large institutional patient-flow base.
- Clinical research has documented approximately 14 ophthalmologists per million population (study benchmark, Vietnam), strengthening the business case for technician-led imaging, remote interpretation and AI-supported case prioritization.
Premium Cataract and Refractive Surgery Offers Mix Upside
- Cao Thang Eye Hospital achieved its 6th JCI accreditation in 2024, demonstrating the role of quality certification in attracting premium domestic and international patients.
- Japan International Eye Hospital reports more than 250,000 visits and 30,000 successful surgeries, indicating scalable economics for high-quality focused ophthalmology centers.
- Vietnam-Russia International Eye Hospital traces its specialist cooperation model to 2007 and currently lists four branches, supporting regional replication of premium refractive and cataract services.
School Myopia Management Creates a Long-Duration Revenue Pool
- A school-screening study reported 24.6% uncorrected refractive error and found roughly two of three affected children lacked appropriate correction, creating a clear access gap.
- Health-insurance amendments effective from 1 January 2025 expanded coverage for strabismus and refractive-error treatment among patients under 18, improving pathways for pediatric intervention.
- A Kon Tum primary-school study of 545 students (2023, Vietnam) found previously diagnosed myopia in 21.1%, supporting school-based screening and preventive-care partnerships.
CHAPTER 9 - Competitive Landscape
Competitive Landscape Overview
Competition is fragmented across national referral hospitals, provincial public institutions and expanding private specialist chains, with technology depth, surgeon reputation, referral access and network scale forming the primary barriers to entry.
Market Share Distribution
Top 5 Players
Market Dynamics
8 new entrants in the past 5 years, indicating strong market attractiveness and growth potential.
Company Name | Market Share | Headquarters | Founding Year | Core Market Focus |
|---|---|---|---|---|
Ho Chi Minh City Eye Hospital | - | Ho Chi Minh City, Vietnam | 1978 | Public tertiary ophthalmology, cataract, retina, cornea and glaucoma |
Central Eye Hospital | - | Hanoi, Vietnam | 1957 | National referral ophthalmology, complex surgery, training and research |
Saigon Eye Hospital | - | Ho Chi Minh City, Vietnam | 2004 | Private ophthalmology chain, refractive surgery, cataract and diagnostics |
Da Nang Eye Hospital | - | Da Nang, Vietnam | - | Regional public eye care, cataract and community ophthalmology |
Vietnam-Russia International Eye Hospital | - | - | 2007 | Refractive surgery, premium cataract and advanced surgical technology |
Hanoi High Tech Eye Hospital | - | Hanoi, Vietnam | 2000 | Private eye hospital, cataract, refraction and outpatient care |
DND International Eye Hospital | - | Hanoi, Vietnam | - | Comprehensive private ophthalmology, diagnostics and surgery |
Cao Thang Eye Hospital | - | Ho Chi Minh City, Vietnam | 2001 | Premium cataract, refractive surgery and international-standard eye care |
Phuong Nam Eye Hospital | - | Ho Chi Minh City, Vietnam | 2013 | Cataract, refraction, outpatient surgery and advanced ophthalmic care |
Japan International Eye Hospital | - | Hanoi, Vietnam | 2014 | Japanese-standard ophthalmology, cataract, diagnostics and specialist care |
Cross Comparison Parameters
The report provides detailed cross-comparison of key players across 10 performance parameters to identify competitive strengths and weaknesses.
Analysis Covered
Market Share Analysis:
Assesses provider scale, patient capture, specialization and competitive concentration nationally.
Cross Comparison Matrix:
Benchmarks procedure capacity, networks, economics and operating execution across providers.
SWOT Analysis:
Identifies technology moats, referral strengths, vulnerabilities and expansion readiness levels.
Pricing Strategy Analysis:
Compares premium procedures, reimbursement exposure and affordability positioning across providers.
Company Profiles:
Reviews ownership, operating footprint, clinical specialization and strategic market positioning.
CHAPTER 10 - REPORT TOC
Table of Contents
Market Assessment Phase
Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.
Go-To-Market Strategy Phase
15 chapters
Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.
Survey Phase
8 chapters
Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers.
Complete Report Coverage
201+ detailed sections covering every aspect of the market
143
Assessment Sections
58
Strategy Sections
CHAPTER 11 - Our Approach
Research Methodology
Desk Research
- Reviewed national eye-health surveillance datasets
- Mapped ophthalmic equipment trade flows
- Analyzed provider network and capacity
- Reviewed reimbursement and device regulation
Primary Research
- Interviewed consultant ophthalmologists and surgeons
- Engaged hospital procurement and operations directors
- Consulted ophthalmic distributor country managers
- Surveyed optometrists and referral coordinators
Validation and Triangulation
- Validated findings across 310 respondents
- Reconciled patient and revenue indicators
- Cross-checked imports and technology adoption
- Tested procedure and referral economics
CHAPTER 12 - FAQ
FAQs
Still have questions?
Our research team is here to help you find the right solution
CHAPTER 13 - Related Research
Explore Related Reports
Expand your market intelligence with complementary research across regions and adjacent markets.
Regional/Country ReportsRelated market analysis across key regions
Related market analysis across key regions
No regional reports found.
Adjacent ReportsRelated markets and complementary research
Related markets and complementary research
No adjacent reports found.
500+
Market Research Reports
50+
Countries Covered
15+
Industry Verticals